Southern blot analysis demonstrated identical immunoglobulin heavy chain gene rearrangements in LCL8664 and in the original tumor mass, thereby verifying that LCL8664 represents the predominant malignant clone (Figure 1). The gene discussed is SLC3A2; the disease is neoplasm.